May 2 |
Top 25 Stocks in the S&P 500 by Index Weight Right Now
|
May 2 |
The top pharmaceutical companies by R&D expenditure
|
May 1 |
BeiGene, AbbVie patent spat to get trial from USPTO appeals board
|
May 1 |
CVS stock plunges after earnings numbers one analyst 'did not even believe'
|
Apr 30 |
Trials to watch: Four ALS drugs to keep an eye on
|
Apr 30 |
AbbVie (ABBV) Could Be a Great Choice
|
Apr 30 |
AbbVie Inc. (NYSE:ABBV) Q1 2024 Earnings Call Transcript
|
Apr 30 |
Earnings Beat: AbbVie Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models
|
Apr 29 |
AbbVie Outlook: Why Humira Biosimilars Won't Undo Huge Sales
|
Apr 29 |
AbbVie: The Inevitable Is Happening
|